The results highlight the crucial role of the TGF-β/SMAD4 signaling pathway in regulating vital cellular processes in cancer growth and suggest potential therapeutic options for targeting this pathway in gallbladder cancer [30]. This evidence concerns the gene SMAD4 and gallbladder cancer.